Bone Marrow Transplantation最新文献

筛选
英文 中文
Correction: Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients. 更正:预测异体造血细胞移植受者呼吸道病毒性疾病进展的新因素。
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-11 DOI: 10.1038/s41409-024-02418-9
Chikara Ogimi, Hu Xie, Alpana Waghmare, Keith R Jerome, Wendy M Leisenring, Masumi Ueda Oshima, Paul A Carpenter, Janet A Englund, Michael Boeckh
{"title":"Correction: Novel factors to predict respiratory viral disease progression in allogeneic hematopoietic cell transplant recipients.","authors":"Chikara Ogimi, Hu Xie, Alpana Waghmare, Keith R Jerome, Wendy M Leisenring, Masumi Ueda Oshima, Paul A Carpenter, Janet A Englund, Michael Boeckh","doi":"10.1038/s41409-024-02418-9","DOIUrl":"https://doi.org/10.1038/s41409-024-02418-9","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study. 桥接 RT 在接受 CAR-T 疗法的复发/难治弥漫大 B 细胞淋巴瘤中的作用:一项多中心研究。
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-09 DOI: 10.1038/s41409-024-02427-8
Stefania Bramanti, Daniele Mannina, Annalisa Chiappella, Beatrice Casadei, Chiara De Philippis, Laura Giordano, Pierina Navarria, Pietro Mancosu, Daniela Taurino, Marta Scorsetti, Carmelo Carlo-Stella, Pierluigi Zinzani, Armando Santoro, Paolo Corradini
{"title":"Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study.","authors":"Stefania Bramanti, Daniele Mannina, Annalisa Chiappella, Beatrice Casadei, Chiara De Philippis, Laura Giordano, Pierina Navarria, Pietro Mancosu, Daniela Taurino, Marta Scorsetti, Carmelo Carlo-Stella, Pierluigi Zinzani, Armando Santoro, Paolo Corradini","doi":"10.1038/s41409-024-02427-8","DOIUrl":"https://doi.org/10.1038/s41409-024-02427-8","url":null,"abstract":"<p><p>The optimization of bridging regimen before chimeric antigen receptor (CAR)-T cell therapy in diffuse large B-cell lymphoma (DLBCL) may impact CAR-T efficacy and outcome. This retrospective study evaluates CAR-T outcome after bridging with radiotherapy (RT) and other bridging strategies. Among 148 patients with relapsed/refractory DLBCL who underwent leukapheresis for CAR-T manufacturing, 31 received RT-bridging, 84 chemotherapy (CT), 33 no-bridging or steroid-only. CAR-T cell were infused in 96.8% of RT-group, 89.2% of CT-group and 78.8% of no-bridge-group (p = 0.079). Response to bridging was generally poor, but patients receiving RT had a significant reduction in LDH levels between pre- and post-bridging (p = 0.05). The one-year PFS was 51.2% in the RT-group, 28.2% in the CT-group, and 47.6% in the no-bridge-group (p = 0.044, CT-bridging vs RT-bridging); 1-year OS was 86.7% in the RT-group, 52.7% in the CT-group and 69% in the no-bridge-group (p = 0.025, CT-bridging vs RT-bridging). We observed a higher incidence of ICANS in patients who received CT than in others (20.0% CT-group, 3.3% RT-group, 7.7% no-bridge group; p = 0.05). In conclusion, RT-bridging is associated with lower drop-out rate and CAR-T toxicity, and it might be preferred to other bridging strategies for patients with localized disease or for those with one prevalent symptomatic site.</p>","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dasatinib maintenance following allogeneic transplantation in acute myeloid leukemia with KIT mutation. KIT突变的急性髓性白血病患者异基因移植后的达沙替尼维持治疗。
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-08 DOI: 10.1038/s41409-024-02425-w
Dat Ngo, Amanda Blackmon, Monzr M Al Malki
{"title":"Dasatinib maintenance following allogeneic transplantation in acute myeloid leukemia with KIT mutation.","authors":"Dat Ngo, Amanda Blackmon, Monzr M Al Malki","doi":"10.1038/s41409-024-02425-w","DOIUrl":"10.1038/s41409-024-02425-w","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR-T cell therapy embarks on autoimmune disease. CAR-T 细胞疗法开始治疗自身免疫性疾病。
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-08 DOI: 10.1038/s41409-024-02429-6
Alexandros Rampotas, Johanna Richter, David Isenberg, Claire Roddie
{"title":"CAR-T cell therapy embarks on autoimmune disease.","authors":"Alexandros Rampotas, Johanna Richter, David Isenberg, Claire Roddie","doi":"10.1038/s41409-024-02429-6","DOIUrl":"https://doi.org/10.1038/s41409-024-02429-6","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation. 在资源有限的国家进行非冷冻自体外周血干细胞移植治疗多发性骨髓瘤和淋巴瘤:全球血液和骨髓移植网络的实践考虑。
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-07 DOI: 10.1038/s41409-024-02431-y
Mohamed Amine Bekadja, Dietger Niederwiser, Mohamed A Kharfan-Dabaja, Riad El Fakih, Laurent Garderet, Ibrahim Yakoub-Agha, Hildegard Greinix, Daniel J Weisdorf, Sebastian Galeano, Syed Osman Ahmed, Christian Chabanon, Shahrukh K Hashmi, Annalisa Ruggeri, Usama Gergis, Ali Bazarbachi, Nada Hamad, Amal Albeihany, Marcelo Pasquini, Amr Hanbali, Jeff Szer, Yoshihisa Kodera, Ambuj Kumar, Tusneem Elhassan, Donal McLornan, Nina Worel, Raffaella Greco, Mohamad Mohty, Yoshiko Atsuta, Mickey Koh, Anna Sureda, Damiano Rondelli, Mahmoud Aljurf, Walid Rasheed
{"title":"Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.","authors":"Mohamed Amine Bekadja, Dietger Niederwiser, Mohamed A Kharfan-Dabaja, Riad El Fakih, Laurent Garderet, Ibrahim Yakoub-Agha, Hildegard Greinix, Daniel J Weisdorf, Sebastian Galeano, Syed Osman Ahmed, Christian Chabanon, Shahrukh K Hashmi, Annalisa Ruggeri, Usama Gergis, Ali Bazarbachi, Nada Hamad, Amal Albeihany, Marcelo Pasquini, Amr Hanbali, Jeff Szer, Yoshihisa Kodera, Ambuj Kumar, Tusneem Elhassan, Donal McLornan, Nina Worel, Raffaella Greco, Mohamad Mohty, Yoshiko Atsuta, Mickey Koh, Anna Sureda, Damiano Rondelli, Mahmoud Aljurf, Walid Rasheed","doi":"10.1038/s41409-024-02431-y","DOIUrl":"https://doi.org/10.1038/s41409-024-02431-y","url":null,"abstract":"<p><p>Autologous peripheral blood stem cell (PBSC) transplantation is a standard treatment of multiple myeloma (MM), Hodgkin lymphoma and various subtypes of non-Hodgkin lymphoma. Cryopreservation of hematopoietic stem cells is standard practice that allows time for delivery of conditioning regimen prior to cell infusion. The aim of this Worldwide Network for Blood & Marrow Transplantation (WBMT) work was to assess existing evidence on non-cryopreserved autologous transplants through a systematic review/meta-analysis, to study feasibility and safety of this approach. We searched PubMed, Web of Science and SCOPUS for studies that utilized non-cryopreserved autologous PBSC transplantation. Identified literature was reviewed for information on mobilization, apheresis, preservation and viability, conditioning regimen, engraftment, response, and survival. Results highlight collective experience from 19 transplant centers (1686 patients), that performed autologous transplants using non-cryopreserved PBSCs. The mean of infused CD34+ was 5.6 × 10<sup>6</sup>/kg. Stem cell viability at transplantation was >90% in MM and >75% in lymphomas, after a storage time of 24-144 h at +4 °C. Mean time-to-neutrophil engraftment was 12 days and 15.3 days for platelets. Pooled proportion estimates of day 100 transplant-related mortality and graft failure were 1% and 0%, respectively. Non-cryopreservation of apheresed autologous PBSCs appears feasible and safe.</p>","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An international survey to better understand the current incidence, severity, and management of VOD/SOS. 为更好地了解 VOD/SOS 目前的发病率、严重程度和管理情况而进行的一项国际调查。
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-07 DOI: 10.1038/s41409-024-02434-9
Marion Larue, Myriam Labopin, Eolia Brissot, Ahmed S Alaskar, Mahmoud Aljurf, Mutlu Arat, Frederic Baron, Ali Bazarbachi, Fabio Ciceri, Selim Corbacioglu, Fiona L Dignan, Michelle Kenyon, Florent Malard, Arnon Nagler, Antonio Pagliuca, Annalisa Ruggeri, Ibrahim Yakoub-Agha, Yishan Ye, Rafael F Duarte, Tapani Ruutu, Enric Carreras, Zinaida Peric, Mohamad Mohty
{"title":"An international survey to better understand the current incidence, severity, and management of VOD/SOS.","authors":"Marion Larue, Myriam Labopin, Eolia Brissot, Ahmed S Alaskar, Mahmoud Aljurf, Mutlu Arat, Frederic Baron, Ali Bazarbachi, Fabio Ciceri, Selim Corbacioglu, Fiona L Dignan, Michelle Kenyon, Florent Malard, Arnon Nagler, Antonio Pagliuca, Annalisa Ruggeri, Ibrahim Yakoub-Agha, Yishan Ye, Rafael F Duarte, Tapani Ruutu, Enric Carreras, Zinaida Peric, Mohamad Mohty","doi":"10.1038/s41409-024-02434-9","DOIUrl":"https://doi.org/10.1038/s41409-024-02434-9","url":null,"abstract":"<p><p>This international questionnaire survey aimed to explore the current incidence, diagnostic policies, management, and outcomes of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) among healthcare providers involved in the management of these patients. A questionnaire was e-mailed to practitioners with an interest in allogeneic hematopoietic cell transplantation (allo-HCT). Of the respondents, 144 of 215 (67.0%) felt that early detection or diagnosis of VOD/SOS was difficult. Regarding diagnostic criteria, 142 (66.1%) already declared using the 2023 EBMT refined criteria. Most respondents (163/215, 75.8%) found these recent refined EBMT criteria useful for diagnosis, and 193 (89.8%) found the severity criteria easy to use. The major risk factors identified for VOD/SOS were a second allo-HCT (41.4%), pre-existing liver disease (54.9%), and prior use of antibody-drug conjugates (49.8%). Preferences for starting VOD/SOS treatment varied, with 61 (28.4%) preferring initiating therapy at a mild stage, and 122 (56.7%) preferring the moderate stage. In summary, this survey provided valuable insight into the challenges and opportunities of the identification and management of VOD/SOS. By improving current knowledge and increasing collaboration among healthcare professionals, early detection, management, and clinical outcomes for patients with this potentially serious complication can also be improved.</p>","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transplant in myeloma: individualized approaches needed depending on context, access and biology. 骨髓瘤的移植:需要根据具体情况、获取途径和生物学特性采取个性化方法。
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-06 DOI: 10.1038/s41409-024-02428-7
Héctor A Vaquera-Alfaro, Andrés Gómez-De León, Nihar Desai, Nikita Mehra, Ghulam Rehman Mohyuddin
{"title":"Transplant in myeloma: individualized approaches needed depending on context, access and biology.","authors":"Héctor A Vaquera-Alfaro, Andrés Gómez-De León, Nihar Desai, Nikita Mehra, Ghulam Rehman Mohyuddin","doi":"10.1038/s41409-024-02428-7","DOIUrl":"https://doi.org/10.1038/s41409-024-02428-7","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142379988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor. 达拉单抗对使用G-CSF和按需普利沙佛进行造血干细胞动员的多发性骨髓瘤患者的采集和移植的影响。
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-04 DOI: 10.1038/s41409-024-02432-x
Giuseppe Bertuglia, Bruno Garibaldi, Andrea Casson, Barbara Sarina, Francesca Gay, Silvio Mercadante, Jacopo Mariotti, Mattia D'agostino, Daniela Taurino, Stefania Oliva, Alessandra Larocca, Daniele Mannina, Chiara De Philippis, Giulia Benevolo, Tiziana Francisci, Marco Lorenzi, Benedetto Bruno, Armando Santoro, Sara Bringhen, Roberto Mina, Stefania Bramanti
{"title":"Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor.","authors":"Giuseppe Bertuglia, Bruno Garibaldi, Andrea Casson, Barbara Sarina, Francesca Gay, Silvio Mercadante, Jacopo Mariotti, Mattia D'agostino, Daniela Taurino, Stefania Oliva, Alessandra Larocca, Daniele Mannina, Chiara De Philippis, Giulia Benevolo, Tiziana Francisci, Marco Lorenzi, Benedetto Bruno, Armando Santoro, Sara Bringhen, Roberto Mina, Stefania Bramanti","doi":"10.1038/s41409-024-02432-x","DOIUrl":"https://doi.org/10.1038/s41409-024-02432-x","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
(Donor) age is more than just a number…. (捐赠者)年龄不仅仅是一个数字....
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-04 DOI: 10.1038/s41409-024-02420-1
Colin Vale, Amelia A Langston
{"title":"(Donor) age is more than just a number….","authors":"Colin Vale, Amelia A Langston","doi":"10.1038/s41409-024-02420-1","DOIUrl":"https://doi.org/10.1038/s41409-024-02420-1","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Significance of men's health in long-term survivors of allogeneic stem cell transplantation. 更正:男性健康对异体干细胞移植长期存活者的意义。
IF 4.5 2区 医学
Bone Marrow Transplantation Pub Date : 2024-10-04 DOI: 10.1038/s41409-024-02415-y
Laila Schneidewind, Thomas Neumann, Nadette Peters, Jennifer Kranz, Kai A Probst, Florian H Heidel, Oliver W Hakenberg, William Krüger
{"title":"Correction: Significance of men's health in long-term survivors of allogeneic stem cell transplantation.","authors":"Laila Schneidewind, Thomas Neumann, Nadette Peters, Jennifer Kranz, Kai A Probst, Florian H Heidel, Oliver W Hakenberg, William Krüger","doi":"10.1038/s41409-024-02415-y","DOIUrl":"https://doi.org/10.1038/s41409-024-02415-y","url":null,"abstract":"","PeriodicalId":9126,"journal":{"name":"Bone Marrow Transplantation","volume":" ","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信